茵陈四苓颗粒对胆汁淤积性肝炎大鼠肝功能损害的改善作用及其机制研究*

doi:10.3969/j.issn.1672-5069.2020.04.006

摘要/Abstract

摘要： 目的探讨茵陈四苓颗粒对胆汁淤积性肝炎大鼠肝功能损害的改善作用及可能的机制。方法将30只SD大鼠随机分为对照组、模型组和茵陈四苓颗粒干预组,采用α-异硫氰酸萘酯(ANIT)灌胃法制备胆汁淤积性肝炎大鼠模型。采用RT-PCR法检测肝组织白介素-17(IL-17)、干扰素-γ(IFN-γ)、超氧化物歧化酶(SOD)和法尼酯X受体(FXR)mRNA水平。结果茵陈四苓颗粒干预组动物血清ALP和GGT水平分别为(254.3±16.4)U/L和(14.3±5.8)U/L,显著低于模型组【分别为(625.8±36.5)U/L和(26.7±7.9)U/L,P＜0.05】;血清IL-17、IFN-γ和丙二醛水平分别为(162.2±16.4)pg/ml、(28.9±6.2)pg/ml和(19.2±3.8)U/ml,显著低于模型组【分别为(223.4±18.8)pg/ml、(39.3±9.8)pg/ml、(28.6±2.4)U/ml,P＜0.05】,而血清SOD水平为(324.1±33.5)U/ml,显著高于模型组【(250.8±25.4)U/ml,P＜0.05】;茵陈四苓颗粒干预组肝组织IL-17和IFN-γ mRNA水平为(2.1±0.3)和(17.3±3.5),显著低于模型组【分别为(3.4±0.5)和(34.5±7.2),P＜0.05】,而SOD和FXR mRNA水平为(0.8±0.4)和(2.2±0.5),显著高于模型组【分别为(0.3±0.2)和(1.5±1.1),P＜0.05】。结论茵陈四苓颗粒能明显改善胆汁淤积性肝炎大鼠肝组织损伤,其机制可能与调控IL-17、IFN-γ和MDA等因子水平,降低炎症反应和提高抗氧化能力有关。

关键词: 胆汁淤积性肝炎, α-异硫氰酸萘酯, 茵陈四苓颗粒, 白介素-17, 法尼酯X受体, 大鼠

Abstract: Objective The aim of this study was to investigate the effect of Yinchen Siling granule, a herbal medicine, on the improvement of liver injuries in rats with alpha-naphthylisothiocyanate (ANIT)-induced cholestatic hepatitis. Method Thirty SD rats were randomly divided into control, model and herbal medicine-intervened group. The interleukin (IL)-17, interferon-γ (IFN-γ), superoxide dismutase (SOD), and farneside x receptor (FXR) mRNA in liver tissues were assayed. Results Serum ALP and GGT levels in herb-intervened group were (254.3±16.4)U/L and (14.3±5.8)U/L, significantly lower than 【(625.8±36.5)U/ and (26.7±7.9)U/L, respectively, P＜0.05】 in the model; serum IL-17, IFN-γ and malondialdehyde levels were (162.2±16.4)pg/ml, (28.9±6.2)pg/ml and (19.2±3.8)U/ml, significantly lower than [(223.4±18.8)pg/ml,(39.3±9.8)pg/ml and (28.6±2.4)U/ml, respectively, P＜0.05], while serum SOD level was (324.1±33.5)U/ml, much higher than [(250.8±25.4)U/ml,P＜0.05]in the model; the IL-17 and IFN-γ mRNA levels in liver tissues in herb-intervened group were (2.1±0.3) and (17.3±3.5), significantly lower than [(3.4±0.5) and (34.5±7.2), P＜0.05],whileSOD and FXR mRNA levels were (0.8±0.4) and (2.2±0.5), much higher than [(0.3±0.2) and(1.5±1.1), P＜0.05]in the model. Conclusion Yinchen Siling granule could significantly improve liver injuries in rats with cholestatic hepatitis, and the mechanism might be related to its alleviating inflammatory reaction and improve antioxidant capacities by regulating IL-17, IFN-γ and other factor expression.

Key words: Cholestatic hepatitis, Alpha-naphthylisothiocyanate, Herbal medicine, Interleukin-17, Farneside x receptor, Rats

杨涓. 茵陈四苓颗粒对胆汁淤积性肝炎大鼠肝功能损害的改善作用及其机制研究^*[J]. 实用肝脏病杂志, 2020, 23(4): 476-479.

Yang Juan. Improvement of liver injuries by herbal medicine in rats with ANTT-induced cholestatic hepatitis[J]. Journal of Practical Hepatology, 2020, 23(4): 476-479.

参考文献

[1]陆伦根.胆汁淤积性肝病临床和基础研究热点和难点.中华肝脏病杂志,2015,23(8):561-563.
[2]Pant C, Jani B S, Desai M, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the nationwide inpatient sample 2002-2012. J Investig Med,2016,64(1):33.
[3]O'Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD‐ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology,2018,67(6):2367-2374.
[4]陈小青,王迎春.肝内胆汁淤积性肝病的病因与治疗.实用肝脏病杂志,2018,21(2):163-165.
[5]Williams GM, Duan JD, Iatropoulos MJ, et al. Sex differences in DNA damage produced by the carcinogen 2-acetylaminofluorene in cultured human hepatocytes compared to rat liver and cultured rat hepatocytes. Arch Toxicol,2016,90(2):427-432.
[6]Ovadia C, Lovgren-Sandblom A, Edwards LA, et al. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action. J Clin Apher,2018,33 (6):638-644.
[7]Blaya D, Coll M, Rodrigotorres D, et al. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut,2016,65(9):1535-1545.
[8]Grine L, Dejager L, Libert C, et al. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytok Growt Fact Rev,2015,26(1):25-33.
[9]Taleb S, Tedgui A, Mallat Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler Thromb Vasc Biol,2015,35(2):258-264.
[10]Zhao Y, Li Y, Wang J, et al. Fluoride induces apoptosis and autophagy through the IL-17 signaling pathway in mice hepatocytes. Arch Toxicol,2018,92 (11):3277-3289.
[11]Abiko K, Matsumura N, Hamanishi J, et al. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br J Cancer,2015,112(9):1501-1509.
[12]Naradikian MS, Myles A, Beiting DP, et al. Cutting edge: IL-4, IL-21, and IFN-γ interact to govern T-bet and CD11c expression in TLR-activated B Cells. J Immunol,2016,197(4):1023-1028.
[13]赵凯,商庆华,宋文刚.γ-干扰素诱生蛋白10与肝病关系研究进展.实用肝脏病杂志,2017,20(1):120-123.
[14]Yuhai G, Zhen Z. Significance of the changes occurring in the levels of interleukins, SOD and MDA in rat pulmonary tissue following exposure to different altitudes and exposure times. Exp Ther Med,2015,10(3):915-920.
[15]Su X, He Y, Yang W, et al. Effect of Dan Hong injection on PON1, SOD activity and MDA levels in elderly patients with coronary heart disease. Int J Clin Exp Med,2014,7(12):5886-5889.
[16]Huang XF, Zhao WY, Huang WD. FXR and liver carcinogenesis. Acta Pharmacol Sin,2015,36(1):37.
[17]Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet,2015,385(9972):956-965.
[18]van Golen RF, Olthof PB, Lionarons DA, et al. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis. Sci Rep,2018,8(1):16529.
[19]Hu YB, Liu XY, Zhan W. Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis. Drug Des Devel Ther,2018,18(12):2213-2221.
[20]丁艳,熊小丽,赵雷,等.法尼醇X受体在大鼠急性淤胆型肝炎中的作用.中华肝脏病杂志,2016,24(6):441-445.

茵陈四苓颗粒对胆汁淤积性肝炎大鼠肝功能损害的改善作用及其机制研究^*

Improvement of liver injuries by herbal medicine in rats with ANTT-induced cholestatic hepatitis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	汪可, 崔现平, 刘丽娟, 支庆江, 姜文营. 蓝莓花青素干预肝硬化大鼠肝组织凋亡蛋白表达的变化^*[J]. 实用肝脏病杂志, 2020, 23(4): 480-483.
[2]	李爽, 刘金玉, 武晓玉, 王宏雅, 刘慧萍, 赵欣, 蔡大勇. 氯膦酸二钠脂质体清除肝内巨噬细胞对CCl₄诱导的慢性肝损伤大鼠门脉高压的影响^*[J]. 实用肝脏病杂志, 2020, 23(4): 484-487.
[3]	胡亦懿, 翟英姬, 梅迪华, 张志侨, 罗晓亮, 黄燕峰, 杜国平. 余甘子提取物对非酒精性脂肪性肝病大鼠外周血Treg细胞及肝组织LXRα/FAS通路表达的影响^*[J]. 实用肝脏病杂志, 2020, 23(4): 488-491.
[4]	唐晓飞,钟梦菊,沈海娟. 柚皮素脂质体对非酒精性脂肪性肝病大鼠脂质代谢的影响及机制研究[J]. 实用肝脏病杂志, 2020, 23(3): 328-331.
[5]	唐新亚,侯森,焦营营. 卡托普利对非酒精性脂肪性肝病大鼠肝细胞脂肪变性的影响[J]. 实用肝脏病杂志, 2020, 23(3): 332-335.
[6]	杜颖,姜志红,吴雅玲. 雷公藤多甙联合异甘草酸镁治疗儿童自身免疫性肝炎疗效及其对血清IL-17和CXCL10水平的影响[J]. 实用肝脏病杂志, 2020, 23(3): 348-351.
[7]	姜佳丽, 李莉, 赵菲, 钟乐萍, 郭子皓, 张川, 展玉涛. 非酒精性脂肪性肝病大鼠肝组织Vaspin表达及其意义探讨^*[J]. 实用肝脏病杂志, 2020, 23(2): 167-170.
[8]	黄橘村, 胡东辉, 张建军, 田德英. 慢病毒介导miR-203过表达对酒精性肝病大鼠肝损伤的保护作用及其机制研究^*[J]. 实用肝脏病杂志, 2020, 23(2): 171-174.
[9]	骆庆玲, 周永健, 唐文娟, 首第文, 黄红丽, 徐豪明, 黄惠康, 何杰, 杜艳蕾, 阮焕梅, 陈慧婷, 曹创裕. 移植NAFLD患者和健康人粪菌对高脂饮食大鼠肠道菌群的影响^*[J]. 实用肝脏病杂志, 2020, 23(1): 134-137.
[10]	徐飞, 李伟荣. 黄芪甲苷对CCL₄所致肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 808-811.
[11]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[12]	林秋香, 王雪雯, 黄祖雄, 潘晨. 灯盏花素对肝脏缺血再灌注损伤大鼠肝脏和肠黏膜屏障功能的保护作用*[J]. 实用肝脏病杂志, 2019, 22(5): 636-639.
[13]	石小龙, 杜睿, 秦革萍, 薛华燕, 张宏鑫. 七氟醚对脓毒症大鼠肝损伤的保护作用及其作用机制研究*[J]. 实用肝脏病杂志, 2019, 22(5): 640-643.
[14]	王艳, 苏峰, 李园园, 李舒. 蜂毒溶血肽改善非酒精性脂肪肝大鼠肝组织脂肪沉积作用及其机制研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 474-477.
[15]	周丽云, 李校天, 李丽, 杨俊超. 1,25（OH）₂D₃通过调节miR-146a水平抑制大鼠肝纤维化的体内和体外观察[J]. 实用肝脏病杂志, 2019, 22(3): 333-336.